MiR-361 targets Yes-associated protein (YAP) mRNA to suppress cell proliferation in lung cancer

被引:18
|
作者
Zhang, Suning [1 ]
Liu, Zongang [1 ]
Wu, Lin [1 ]
Wang, Yudong [1 ]
机构
[1] China Med Univ, Shengjing Hosp Affiliated, Dept Thorac Surg, Shenyang 110000, Liaoning, Peoples R China
关键词
miR-361; YAP; Proliferation; Lung cancer; HIPPO PATHWAY; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL COACTIVATOR; PROMOTES APOPTOSIS; CONTACT INHIBITION; OVARIAN-CANCER; SIZE-CONTROL; ORGAN SIZE; WW DOMAIN; GROWTH;
D O I
10.1016/j.bbrc.2017.08.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Yes-associated protein (YAP) contributes to the development of multiple tumors, but the post transcription modulation of YAP remains unexplored. Here, we present a new regulatory microRNA of YAP, miR-361, which directly targets YAP to inhibit cell proliferation in lung cancer. We used bioinformatics to predict that miR-361 could target 3'-untranslated region (3'UTR) of YAP mRNA. Luciferase reporter gene assays demonstrated that miR-361 could decrease the luciferase activities of 3'UTR vector of YAP. Furthermore, YAP expression was obviously abated by miR-361 using RT-PCR and immunoblotting in lung cancer A549 cells. In terms of function, MTT and colony formation analysis showed that ectopic miR-361 expression significantly suppressed cell proliferation in lung cancer. Notably, overexpressed YAP accelerated miR-361-bated proliferation of lung cancer cells. MiR-361 inhibitor promoted cell proliferation in lung cancer, but YAP RNA interference reversed miR-361 inhibitor-driven cell proliferation. Interestingly, miR-361 was capable of affecting the cell cycle in lung cancer progression. Finally, the negative correlation of miR-361 with YAP was found in clinical human lung cancer tissues. In conclusion, miR-361 targets 3'UTR of YAP mRNA to depress the proliferation of lung cancer cells. (C) 2017 Published by Elsevier Inc.
引用
收藏
页码:468 / 473
页数:6
相关论文
共 50 条
  • [1] microRNA-625 targets Yes-associated protein 1 to suppress cell proliferation and invasion of osteosarcoma
    Luo, Zheng
    Wu, Gang
    Zhang, Daiyang
    Liu, Jun
    Ran, Renguo
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 2005 - 2011
  • [2] Dual roles of yes-associated protein (YAP) in colorectal cancer
    Ou, Chunlin
    Sun, Zhenqiang
    Li, Shen
    Li, Guiyuan
    Li, Xiayu
    Ma, Jian
    ONCOTARGET, 2017, 8 (43) : 75727 - 75741
  • [3] Expression of Yes-associated protein (YAP) in metastatic breast cancer
    Kim, Hye Min
    Jung, Woo Hee
    Koo, Ja Seung
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11248 - 11257
  • [4] YES-ASSOCIATED PROTEIN (YAP) IS REQUIRED FOR THE CLONAL EXPANSION OF PRENEOPLASTIC HEPATOCYTES AND OVAL CELL PROLIFERATION
    Kowalik, M. A.
    Perra, A.
    Ghiso, E.
    Ledda-Columbano, G. M.
    Giordano, S.
    Columbano, A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S86 - S86
  • [5] Expression of Yes-associated protein (YAP) in clear cell renal cell carcinoma
    Schuette, U.
    Bisht, S.
    Beckers, A.
    Esch, C.
    Heukamp, L. C.
    Zhou, H.
    Buettner, R.
    Brossart, P.
    Feldmann, G.
    ONKOLOGIE, 2010, 33 : 128 - 128
  • [6] Downregulation of Yes-associated protein 1 (YAP1) expression reduces cell proliferation and clonogenicity of pancreatic cancer cells
    Diep, Caroline H.
    Zucker, Kelly
    Watanabe, April'
    Hostetter, Galen
    Munoz, Ruben
    Von Hoff, Daniel D.
    Han, Haiyong
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] miR-194 Inhibits Ovarian Cancer Cell Proliferation and Reduces Cisplatin Resistance by Targeting Yes-Associated Protein
    Tang, Hao
    Gong, Ping
    Tao, Ling
    Hua, Yurong
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (08) : 1170 - 1175
  • [8] Yes-Associated Protein (YAP) is a Key Factor for Improving the Management of Cancer Treatments
    Sushun Liu
    Jingyao Zhang
    Qing Pang
    Mimi Zhai
    Chang Liu
    Annals of Surgical Oncology, 2017, 24 : 642 - 643
  • [9] Yes-Associated Protein (YAP) is a Key Factor for Improving the Management of Cancer Treatments
    Liu, Sushun
    Zhang, Jingyao
    Pang, Qing
    Zhai, Mimi
    Liu, Chang
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S642 - S643
  • [10] Yes-associated protein (YAP) silencing as a new therapeutic strategy for ovarian cancer
    Roh, J. W.
    Kim, J.
    Choi, H.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 99 - 99